New CTD: "Downer" | PVCT Message Board Posts


Provectus Biopharmaceuticals, Inc.

  PVCT website

PVCT   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  13767 of 60147  at  5/19/2015 11:21:47 AM  by

Hombre77


 In response to msg 13755 by  living xxl
view thread

Re: New CTD: "Downer"

Dom's latest says (among other things) the following about ESMO:

"Provectus Poster Presentation on PV-10 Clinical Data from Phase 1 Study for Cancers of the Liver Scheduled for Thursday, July 2, 2015 at 17th World Congress on Gastrointestinal Cancer. Dr. Sanjiv Agarwala is the lead author/presenter. Judging from the presentation times (10:30 to 11:00 a.m. and 4:55 to 5:25 p.m. local time) and the conference's scientific program, Agarwala and the poster appear to be in the Esophageal Cancer (which doesn't make sense to me) and Rare Tumors: Neuroendocrine Tumors, Gastrointestinal Stromal Tumors and Anal Cancer sessions, respectively."

I think he's got it wrong when he associates PVCT's poster presentations with the specific conference sessions referenced above. Although there are some parallel conference sessions running in the morning, they're all adjourned by the poster session time slot. So the fact that the poster sessions happen to show up tacked on to the end of the specific sessions referenced by Dom is irrelevant. The organizers probably should have given the poster sessions their own heading, but didn't.

I would also note that Dom seems to have missed the fact that the second poster session is scheduled to occur immediately prior to the "Liver Malignancy" session, which is obviously of more relevance.


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 0  
   Views: 325 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board




Financial Market Data provided by
.
Loading...